Arcadia Biosciences Stock Price on April 8, 2024
| RKDA Stock | USD 2.74 0.15 5.79% |
Below is the normalized historical share price chart for Arcadia Biosciences extending back to May 15, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arcadia Biosciences stands at 2.74, as last reported on the 24th of November, with the highest price reaching 2.74 and the lowest price hitting 2.65 during the day.
If you're considering investing in Arcadia Stock, it is important to understand the factors that can impact its price. At this point, Arcadia Biosciences is unstable. Arcadia Biosciences secures Sharpe Ratio (or Efficiency) of 0.009, which signifies that the company had a 0.009% return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Arcadia Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Arcadia Biosciences' mean deviation of 4.47, and Risk Adjusted Performance of 0.0312 to double-check if the risk estimate we provide is consistent with the expected return of 0.0616%.
At present, Arcadia Biosciences' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 1.3 M, whereas Other Stockholder Equity is forecasted to decline to about 207.1 M. . At present, Arcadia Biosciences' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price To Sales Ratio is forecasted to decline to 0.69. Arcadia Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of May 2015 | 200 Day MA 2.8319 | 50 Day MA 3.3262 | Beta 1.275 |
Arcadia |
Sharpe Ratio = 0.009
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | RKDA |
| Negative Returns |
Estimated Market Risk
| 6.86 actual daily | 61 61% of assets are less volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Arcadia Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcadia Biosciences by adding Arcadia Biosciences to a well-diversified portfolio.
Price Book 0.3636 | Enterprise Value Ebitda 0.6173 | Price Sales 0.7216 | Shares Float 1.4 M | Wall Street Target Price 9 |
Arcadia Biosciences Valuation on April 8, 2024
It is possible to determine the worth of Arcadia Biosciences on a given historical date. On April 8, 2024 Arcadia was worth 2.17 at the beginning of the trading date compared to the closed value of 2.09. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arcadia Biosciences stock. Still, in general, we apply an absolute valuation method to find Arcadia Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arcadia Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arcadia Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 2.10 | 2.15 | 2.04 | 2.15 | 22,231 | |
04/08/2024 | 2.17 | 2.19 | 2.03 | 2.09 | 15,128 |
| 2.07 | 2.07 | 2.03 | 2.04 | 7,593 |
| Backtest Arcadia Biosciences | | | Arcadia Biosciences History | | | Arcadia Biosciences Valuation | Previous | Next |
Arcadia Biosciences Trading Date Momentum on April 8, 2024
| On April 09 2024 Arcadia Biosciences was traded for 2.04 at the closing time. The top price for the day was 2.07 and the lowest listed price was 2.03 . The trading volume for the day was 7.6 K. The trading history from April 9, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.39% . The overall trading delta against the current closing price is 2.39% . |
Arcadia Biosciences Fundamentals Correlations and Trends
By evaluating Arcadia Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arcadia Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arcadia financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Arcadia Biosciences Stock history
Arcadia Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arcadia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arcadia Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arcadia Biosciences stock prices may prove useful in developing a viable investing in Arcadia Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.2 M | 1.3 M | |
| Net Loss | -16.9 M | -17.7 M |
Arcadia Biosciences Quarterly Net Working Capital |
|
Arcadia Biosciences Stock Technical Analysis
Arcadia Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Arcadia Biosciences Period Price Range
Low | November 24, 2024
| High |
0.00 | 0.00 |
Arcadia Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Arcadia Biosciences November 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Arcadia Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arcadia Biosciences shares will generate the highest return on investment. By undertsting and applying Arcadia Biosciences stock market strength indicators, traders can identify Arcadia Biosciences entry and exit signals to maximize returns
Arcadia Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arcadia Biosciences' price direction in advance. Along with the technical and fundamental analysis of Arcadia Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arcadia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0312 | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.89) | |||
| Sortino Ratio | 0.0093 | |||
| Treynor Ratio | 0.0703 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Arcadia Stock analysis
When running Arcadia Biosciences' price analysis, check to measure Arcadia Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcadia Biosciences is operating at the current time. Most of Arcadia Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcadia Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcadia Biosciences' price. Additionally, you may evaluate how the addition of Arcadia Biosciences to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |